Jon Cohen (@sciencecohen) 's Twitter Profile
Jon Cohen

@sciencecohen

Science magazine staff writer on infectious diseases, outbreaks, immunology, vaccines, global health, genomics, CRISPR, surfing. Views mine. @[email protected]

ID: 34020042

linkhttp://www.joncohen.org calendar_today21-04-2009 19:59:26

3,3K Tweet

41,41K Followers

1,1K Following

Jon Cohen (@sciencecohen) 's Twitter Profile Photo

This paper has fascinating details and carefully documents how recombination happens in individual bats. The SARS-CoV/SARS-CoV-2 mash up, BtSY2, is gulp inducing.

Jon Cohen (@sciencecohen) 's Twitter Profile Photo

As story explains, this isn't all-or-nothing phenomenon. “I think of interference as a small push,” says Aubree Gordon....“It depends on population immunity and when that virus last circulated and flu and COVID vaccination rates.” But interference is a real phenomenon.

Jon Cohen (@sciencecohen) 's Twitter Profile Photo

Ask Alessandro Sette. I'm not aware of any compelling evidence that SARS-CoV-2 depletion of T or B cells has any significant, longterm impact on the immune system's ability to replace them. SRCV2 doesn't target immune cells, and it's not HIV.

Jon Cohen (@sciencecohen) 's Twitter Profile Photo

Here's the kind of problem you want to have: Uganda's Ebola cases are dwindling thanks to aggressive containment efforts, but success complicates plans for a rapidly organized trial to do first read-world test of vaccines against Sudan ebolavirus. science.org/content/articl…

Here's the kind of problem you want to have: Uganda's Ebola cases are dwindling thanks to aggressive containment efforts, but success complicates plans for a rapidly organized trial to do first read-world test of vaccines against Sudan ebolavirus.

science.org/content/articl…